Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if OSRH is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
2 top institutions tracked
Sentiment: unknown
No recent insider trades detected.
Red flags: 0
14 filers reported a long position in OSRH for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| VANGUARD FIDUCIARY TRUST CO | $46.9K | 148.3K | +770.7% |
| CITADEL ADVISORS LLC | $40.4K | 127.8K | New |
| JANE STREET GROUP, LLC | $40.2K | 127.2K | New |
| GEODE CAPITAL MANAGEMENT, LLC | $31.8K | 100.5K | -5% |
| TWO SIGMA SECURITIES, LLC | $14.7K | 46.5K | New |
| VANGUARD CAPITAL MANAGEMENT LLC | $11.8K | 37.4K | Unchanged |
| XTX Topco Ltd | $10.2K | 32.4K | -46.7% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $5.8K | 18.3K | New |
| NORTHERN TRUST CORP | $3.5K | 10.9K | New |
| Tower Research Capital LLC (TRC) | $2.1K | 6.6K | +59.1% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.